Neurovascular Stent Market Report

Global Neurovascular Stent Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 11, 2022
  • PAGES：136
  • REPORT CODE：GMM809983
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Neurovascular Stent market report explains the definition, types, applications, major countries, and major players of the Neurovascular Stent market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Abbott Laboratories (USA)

    • Cordis (USA)

    • Medtronic (USA)

    • Stryker (USA)

    • Terumo Medical (Japan)

    • Johnson & Johnson (USA)

    • Acandis (Germany)

    • Gore Medical (USA)

    • MicroPort Scientific (China)

    By Type:

    • Carotid artery stents

    • Intracranial stents

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Neurovascular Stent Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Neurovascular Stent Outlook to 2028- Original Forecasts

    • 2.2 Neurovascular Stent Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Neurovascular Stent Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Neurovascular Stent Market- Recent Developments

    • 6.1 Neurovascular Stent Market News and Developments

    • 6.2 Neurovascular Stent Market Deals Landscape

    7 Neurovascular Stent Raw Materials and Cost Structure Analysis

    • 7.1 Neurovascular Stent Key Raw Materials

    • 7.2 Neurovascular Stent Price Trend of Key Raw Materials

    • 7.3 Neurovascular Stent Key Suppliers of Raw Materials

    • 7.4 Neurovascular Stent Market Concentration Rate of Raw Materials

    • 7.5 Neurovascular Stent Cost Structure Analysis

      • 7.5.1 Neurovascular Stent Raw Materials Analysis

      • 7.5.2 Neurovascular Stent Labor Cost Analysis

      • 7.5.3 Neurovascular Stent Manufacturing Expenses Analysis

    8 Global Neurovascular Stent Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Neurovascular Stent Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Neurovascular Stent Export by Region (Top 10 Countries) (2017-2028)

    9 Global Neurovascular Stent Market Outlook by Types and Applications to 2022

    • 9.1 Global Neurovascular Stent Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Carotid artery stents Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Intracranial stents Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neurovascular Stent Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Neurovascular Stent Market Analysis and Outlook till 2022

    • 10.1 Global Neurovascular Stent Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Neurovascular Stent Consumption (2017-2022)

      • 10.2.2 Canada Neurovascular Stent Consumption (2017-2022)

      • 10.2.3 Mexico Neurovascular Stent Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Neurovascular Stent Consumption (2017-2022)

      • 10.3.2 UK Neurovascular Stent Consumption (2017-2022)

      • 10.3.3 Spain Neurovascular Stent Consumption (2017-2022)

      • 10.3.4 Belgium Neurovascular Stent Consumption (2017-2022)

      • 10.3.5 France Neurovascular Stent Consumption (2017-2022)

      • 10.3.6 Italy Neurovascular Stent Consumption (2017-2022)

      • 10.3.7 Denmark Neurovascular Stent Consumption (2017-2022)

      • 10.3.8 Finland Neurovascular Stent Consumption (2017-2022)

      • 10.3.9 Norway Neurovascular Stent Consumption (2017-2022)

      • 10.3.10 Sweden Neurovascular Stent Consumption (2017-2022)

      • 10.3.11 Poland Neurovascular Stent Consumption (2017-2022)

      • 10.3.12 Russia Neurovascular Stent Consumption (2017-2022)

      • 10.3.13 Turkey Neurovascular Stent Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Neurovascular Stent Consumption (2017-2022)

      • 10.4.2 Japan Neurovascular Stent Consumption (2017-2022)

      • 10.4.3 India Neurovascular Stent Consumption (2017-2022)

      • 10.4.4 South Korea Neurovascular Stent Consumption (2017-2022)

      • 10.4.5 Pakistan Neurovascular Stent Consumption (2017-2022)

      • 10.4.6 Bangladesh Neurovascular Stent Consumption (2017-2022)

      • 10.4.7 Indonesia Neurovascular Stent Consumption (2017-2022)

      • 10.4.8 Thailand Neurovascular Stent Consumption (2017-2022)

      • 10.4.9 Singapore Neurovascular Stent Consumption (2017-2022)

      • 10.4.10 Malaysia Neurovascular Stent Consumption (2017-2022)

      • 10.4.11 Philippines Neurovascular Stent Consumption (2017-2022)

      • 10.4.12 Vietnam Neurovascular Stent Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Neurovascular Stent Consumption (2017-2022)

      • 10.5.2 Colombia Neurovascular Stent Consumption (2017-2022)

      • 10.5.3 Chile Neurovascular Stent Consumption (2017-2022)

      • 10.5.4 Argentina Neurovascular Stent Consumption (2017-2022)

      • 10.5.5 Venezuela Neurovascular Stent Consumption (2017-2022)

      • 10.5.6 Peru Neurovascular Stent Consumption (2017-2022)

      • 10.5.7 Puerto Rico Neurovascular Stent Consumption (2017-2022)

      • 10.5.8 Ecuador Neurovascular Stent Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Neurovascular Stent Consumption (2017-2022)

      • 10.6.2 Kuwait Neurovascular Stent Consumption (2017-2022)

      • 10.6.3 Oman Neurovascular Stent Consumption (2017-2022)

      • 10.6.4 Qatar Neurovascular Stent Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Neurovascular Stent Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Neurovascular Stent Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Neurovascular Stent Consumption (2017-2022)

      • 10.7.2 South Africa Neurovascular Stent Consumption (2017-2022)

      • 10.7.3 Egypt Neurovascular Stent Consumption (2017-2022)

      • 10.7.4 Algeria Neurovascular Stent Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Neurovascular Stent Consumption (2017-2022)

      • 10.8.2 New Zealand Neurovascular Stent Consumption (2017-2022)

    11 Global Neurovascular Stent Competitive Analysis

    • 11.1 Abbott Laboratories (USA)

      • 11.1.1 Abbott Laboratories (USA) Company Details

      • 11.1.2 Abbott Laboratories (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Abbott Laboratories (USA) Neurovascular Stent Main Business and Markets Served

      • 11.1.4 Abbott Laboratories (USA) Neurovascular Stent Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Cordis (USA)

      • 11.2.1 Cordis (USA) Company Details

      • 11.2.2 Cordis (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Cordis (USA) Neurovascular Stent Main Business and Markets Served

      • 11.2.4 Cordis (USA) Neurovascular Stent Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Medtronic (USA)

      • 11.3.1 Medtronic (USA) Company Details

      • 11.3.2 Medtronic (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Medtronic (USA) Neurovascular Stent Main Business and Markets Served

      • 11.3.4 Medtronic (USA) Neurovascular Stent Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Stryker (USA)

      • 11.4.1 Stryker (USA) Company Details

      • 11.4.2 Stryker (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Stryker (USA) Neurovascular Stent Main Business and Markets Served

      • 11.4.4 Stryker (USA) Neurovascular Stent Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Terumo Medical (Japan)

      • 11.5.1 Terumo Medical (Japan) Company Details

      • 11.5.2 Terumo Medical (Japan) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Terumo Medical (Japan) Neurovascular Stent Main Business and Markets Served

      • 11.5.4 Terumo Medical (Japan) Neurovascular Stent Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Johnson & Johnson (USA)

      • 11.6.1 Johnson & Johnson (USA) Company Details

      • 11.6.2 Johnson & Johnson (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Johnson & Johnson (USA) Neurovascular Stent Main Business and Markets Served

      • 11.6.4 Johnson & Johnson (USA) Neurovascular Stent Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Acandis (Germany)

      • 11.7.1 Acandis (Germany) Company Details

      • 11.7.2 Acandis (Germany) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Acandis (Germany) Neurovascular Stent Main Business and Markets Served

      • 11.7.4 Acandis (Germany) Neurovascular Stent Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Gore Medical (USA)

      • 11.8.1 Gore Medical (USA) Company Details

      • 11.8.2 Gore Medical (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Gore Medical (USA) Neurovascular Stent Main Business and Markets Served

      • 11.8.4 Gore Medical (USA) Neurovascular Stent Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 MicroPort Scientific (China)

      • 11.9.1 MicroPort Scientific (China) Company Details

      • 11.9.2 MicroPort Scientific (China) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 MicroPort Scientific (China) Neurovascular Stent Main Business and Markets Served

      • 11.9.4 MicroPort Scientific (China) Neurovascular Stent Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Neurovascular Stent Market Outlook by Types and Applications to 2028

    • 12.1 Global Neurovascular Stent Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Carotid artery stents Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Intracranial stents Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Neurovascular Stent Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Neurovascular Stent Market Analysis and Outlook to 2028

    • 13.1 Global Neurovascular Stent Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.2.2 Canada Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Neurovascular Stent Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.2 UK Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.3 Spain Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.5 France Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.6 Italy Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.8 Finland Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.9 Norway Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.11 Poland Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.12 Russia Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Neurovascular Stent Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.2 Japan Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.3 India Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Neurovascular Stent Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.5.3 Chile Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.5.6 Peru Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Neurovascular Stent Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.6.3 Oman Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Neurovascular Stent Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Neurovascular Stent Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Neurovascular Stent Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Neurovascular Stent Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Neurovascular Stent

    • Figure of Neurovascular Stent Picture

    • Table Global Neurovascular Stent Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Neurovascular Stent Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Carotid artery stents Consumption and Growth Rate (2017-2022)

    • Figure Global Intracranial stents Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Neurovascular Stent Consumption by Country (2017-2022)

    • Table North America Neurovascular Stent Consumption by Country (2017-2022)

    • Figure United States Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Canada Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Mexico Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Table Europe Neurovascular Stent Consumption by Country (2017-2022)

    • Figure Germany Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure UK Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Spain Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Belgium Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure France Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Italy Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Denmark Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Finland Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Norway Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Sweden Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Poland Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Russia Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Turkey Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Table APAC Neurovascular Stent Consumption by Country (2017-2022)

    • Figure China Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Japan Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure India Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Thailand Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Singapore Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Philippines Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Table South America Neurovascular Stent Consumption by Country (2017-2022)

    • Figure Brazil Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Colombia Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Chile Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Argentina Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Peru Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Table GCC Neurovascular Stent Consumption by Country (2017-2022)

    • Figure Bahrain Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Oman Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Qatar Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Table Africa Neurovascular Stent Consumption by Country (2017-2022)

    • Figure Nigeria Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure South Africa Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Egypt Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure Algeria Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Table Oceania Neurovascular Stent Consumption by Country (2017-2022)

    • Figure Australia Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Neurovascular Stent Consumption and Growth Rate (2017-2022)

    • Table Abbott Laboratories (USA) Company Details

    • Table Abbott Laboratories (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories (USA) Neurovascular Stent Main Business and Markets Served

    • Table Abbott Laboratories (USA) Neurovascular Stent Product Portfolio

    • Table Cordis (USA) Company Details

    • Table Cordis (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cordis (USA) Neurovascular Stent Main Business and Markets Served

    • Table Cordis (USA) Neurovascular Stent Product Portfolio

    • Table Medtronic (USA) Company Details

    • Table Medtronic (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic (USA) Neurovascular Stent Main Business and Markets Served

    • Table Medtronic (USA) Neurovascular Stent Product Portfolio

    • Table Stryker (USA) Company Details

    • Table Stryker (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stryker (USA) Neurovascular Stent Main Business and Markets Served

    • Table Stryker (USA) Neurovascular Stent Product Portfolio

    • Table Terumo Medical (Japan) Company Details

    • Table Terumo Medical (Japan) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Medical (Japan) Neurovascular Stent Main Business and Markets Served

    • Table Terumo Medical (Japan) Neurovascular Stent Product Portfolio

    • Table Johnson & Johnson (USA) Company Details

    • Table Johnson & Johnson (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson (USA) Neurovascular Stent Main Business and Markets Served

    • Table Johnson & Johnson (USA) Neurovascular Stent Product Portfolio

    • Table Acandis (Germany) Company Details

    • Table Acandis (Germany) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acandis (Germany) Neurovascular Stent Main Business and Markets Served

    • Table Acandis (Germany) Neurovascular Stent Product Portfolio

    • Table Gore Medical (USA) Company Details

    • Table Gore Medical (USA) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gore Medical (USA) Neurovascular Stent Main Business and Markets Served

    • Table Gore Medical (USA) Neurovascular Stent Product Portfolio

    • Table MicroPort Scientific (China) Company Details

    • Table MicroPort Scientific (China) Neurovascular Stent Sales, Price, Value and Gross Profit (2017-2022)

    • Table MicroPort Scientific (China) Neurovascular Stent Main Business and Markets Served

    • Table MicroPort Scientific (China) Neurovascular Stent Product Portfolio

    • Figure Global Carotid artery stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intracranial stents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurovascular Stent Consumption Forecast by Country (2022-2028)

    • Table North America Neurovascular Stent Consumption Forecast by Country (2022-2028)

    • Figure United States Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neurovascular Stent Consumption Forecast by Country (2022-2028)

    • Figure Germany Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Neurovascular Stent Consumption Forecast by Country (2022-2028)

    • Figure China Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Neurovascular Stent Consumption Forecast by Country (2022-2028)

    • Figure Brazil Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Neurovascular Stent Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Neurovascular Stent Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Neurovascular Stent Consumption Forecast by Country (2022-2028)

    • Figure Australia Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Neurovascular Stent Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US